OTC · Biotechnology

HST Global, Inc. (HSTC) Stock

$0.70 +0.00% OTC: HSTC Healthcare

HST Global, Inc. operates as a biotechnology firm dedicated to integrated health and wellness.

Valuation

MetricValue
Price$0.70
Market Cap$29.94M
P/E Ratio-250.00
P/B Ratio8.10
P/S Ratio38.99
EPS (TTM)$-0.01
52-Week High$1.05
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.64%
ROA-3.33%
ROCE-2.83%
Gross Margin79.41%
Operating Margin-45.88%
Net Margin-57.64%
Debt/Equity0.08
Current Ratio0.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$0$0$0$0$-1.0M
Net Profit$0$0$0$0$-1.0M
EPS$-0.03$-0.03$-0.03$0.00$-0.01
Op Margin————-154.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$6.0M$13.0M
Total Liabilities$0$0$1.0M$1.0M$1.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$1.0M$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-3.13
EV / EBITDA-158.83
FCF Yield-4.97%
Quick Ratio0.32
Interest Coverage-3.90
Return 1Y174900.00%
Return 3Y309.36%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARDSAridis Pharmaceuticals, Inc. $0.00 — 0.00 $4457 0.00%
BTAXBiostax Corp. $0.00 — 0.00 $7871 0.00%
EVLOEvelo Biosciences, Inc. $0.00 — 0.00 $1898 0.00%
GSRXGSRX Industries Inc. $0.00 — 0.00 $8180 0.00%
INFIQInfinity Pharmaceuticals, Inc. $0.00 — 0.00 $9076 0.00%

About HST Global, Inc.

HST Global, Inc. operates as a biotechnology firm dedicated to integrated health and wellness. The company establishes and acquires a global network of specialized wellness centers, which offer homeopathic and alternative treatments primarily for patients suffering from advanced-stage cancers. Furthermore, HST Global focuses on the development of homeopathic and alternative therapeutic candidates that are either currently undergoing or have successfully completed clinical trials. These potential treatments are designed to address late-stage cancers as well as various other critical, life-threatening conditions. The company's corporate headquarters are situated in Hampton, Virginia.

HST Global, Inc. is headquartered in US.

HST Global, Inc. (HSTC) stock trades at $0.70 with a market capitalization of $29.94M. The stock is valued at a price-to-earnings (P/E) ratio of -250.00, price-to-book of 8.10, price-to-sales of 38.99. Over the past 52 weeks the stock has ranged between $0.00 and $1.05, and currently trades 33.3% below its 52-week high.

On profitability, HST Global, Inc. generates a return on equity (ROE) of -3.64%, return on capital employed of -2.83%, an operating margin of -45.88%, a net profit margin of -57.64%.

Official website: www.hstglobal.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides